Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 10261-10270 of 11953

Edit search filters
  1. VEXAS Biobank

    Rochester, MN

  2. Practice and Education Gaps in Cosmetic Dermatology

    Rochester, MN

  3. Mediators of insulin resistance in women with a history of gestational diabetes mellitus

    Rochester, MN

  4. A Study to Optimize Patient Selection and Outcomes in Laryngeal Vascular Composite Allograft Transplantation

    Scottsdale/Phoenix, AZ

  5. Biobank Protocol, Rare Diseases Clinical Research Network

    Rochester, MN

  6. Identification Of Predictors For Clinical Outcomes In Femoroacetabular Impingement Surgery

    Rochester, MN

  7. Development Of A Novel Endoscopic Index And Patient-reported Outcome Measure For Clinical Trials In Participants With Permanent Ileostomy

    Rochester, MN

  8. A Study To Predict Lung Cancer Using Noninvasive Biomarkers

    Rochester, MN

  9. Brain Tumor Induced Immunosuppression

    Rochester, MN

  10. A Study Of New Outcome Measures To Assess The Progression Of Amyotrophic Lateral Sclerosis

    Rochester, MN

.

Mayo Clinic Footer